276 related articles for article (PubMed ID: 33996812)
1. β-Arrestin1 Promotes Colorectal Cancer Metastasis Through GSK-3β/β-Catenin Signaling- Mediated Epithelial-to-Mesenchymal Transition.
Song Q; Han Z; Wu X; Wang Y; Zhou L; Yang L; Liu N; Sui H; Cai J; Ji Q; Li Q
Front Cell Dev Biol; 2021; 9():650067. PubMed ID: 33996812
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer.
Song Q; Yang L; Han Z; Wu X; Li R; Zhou L; Liu N; Sui H; Cai J; Wang Y; Ji Q; Li Q
Front Pharmacol; 2020; 11():586616. PubMed ID: 33192529
[TBL] [Abstract][Full Text] [Related]
3. β-arrestin1 promotes epithelial-mesenchymal transition via modulating GSK-3β/β-catenin pathway in prostate cancer cells.
Duan X; Zhang T; Kong Z; Mai X; Lan C; Chen D; Liu Y; Zeng Z; Cai C; Deng T; Wu W; Zeng G
Biochem Biophys Res Commun; 2016 Oct; 479(2):204-210. PubMed ID: 27620488
[TBL] [Abstract][Full Text] [Related]
4. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
[TBL] [Abstract][Full Text] [Related]
5. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
6. WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway.
Yang D; Li Q; Shang R; Yao L; Wu L; Zhang M; Zhang L; Xu M; Lu Z; Zhou J; Huang L; Huang X; Cheng D; Yang Y; Yu H
J Exp Clin Cancer Res; 2020 Nov; 39(1):251. PubMed ID: 33222684
[TBL] [Abstract][Full Text] [Related]
7. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
Tao L; Zhu Y; Gu Y; Zheng J; Yang J
Eur J Pharmacol; 2019 Sep; 858():172476. PubMed ID: 31228451
[TBL] [Abstract][Full Text] [Related]
8. SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.
Hu TH; Yao Y; Yu S; Han LL; Wang WJ; Guo H; Tian T; Ruan ZP; Kang XM; Wang J; Wang SH; Nan KJ
Cancer Lett; 2014 Nov; 354(2):417-26. PubMed ID: 25150783
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of ADAM 12 Regulates Epithelial-mesenchymal Transition by Activating the Wnt/β-catenin Signaling Pathway in Colorectal Cancer.
Huang C; Wang J; Xiang J; Wu C; Wang F; Chen J; Sun G; Xiang D
Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38716545
[TBL] [Abstract][Full Text] [Related]
10. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
11. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
12. NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the Wnt/β-catenin signaling pathway.
Shi Y; Ge C; Fang D; Wei W; Li L; Wei Q; Yu H
Cancer Cell Int; 2022 Mar; 22(1):119. PubMed ID: 35292013
[TBL] [Abstract][Full Text] [Related]
13. GLDC promotes colorectal cancer metastasis through epithelial-mesenchymal transition mediated by Hippo signaling pathway.
Yu H; Hu X; Zhang Y; Wang J; Ni Z; Wang Y; Zhu H
Med Oncol; 2023 Sep; 40(10):293. PubMed ID: 37668829
[TBL] [Abstract][Full Text] [Related]
14. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells.
Sun L; Xing J; Zhou X; Song X; Gao S
Biomed Pharmacother; 2024 Jun; 175():116685. PubMed ID: 38710151
[TBL] [Abstract][Full Text] [Related]
16. SNX3 suppresses the migration and invasion of colorectal cancer cells by reversing epithelial-to-mesenchymal transition via the β-catenin pathway.
Pan B; Zhang T; Yang W; Liu Y; Chen Y; Zhou Z; Tang Y; Zeng J; Liu Y; Zhao C; Guo Y
Oncol Lett; 2019 Nov; 18(5):5332-5340. PubMed ID: 31612043
[TBL] [Abstract][Full Text] [Related]
17. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
[TBL] [Abstract][Full Text] [Related]
19. KLHL22 Regulates the EMT and Proliferation in Colorectal Cancer Cells in Part via the Wnt/β-Catenin Signaling Pathway.
Song Y; Yuan H; Wang J; Wu Y; Xiao Y; Mao S
Cancer Manag Res; 2020; 12():3981-3993. PubMed ID: 32547233
[TBL] [Abstract][Full Text] [Related]
20. Sanguinarine suppresses migration and metastasis in colorectal carcinoma associated with the inversion of EMT through the Wnt/β-catenin signaling.
Zhu M; Gong Z; Wu Q; Shi X; Su Q; Zhang Y
Clin Transl Med; 2020 Jan; 10(1):1-12. PubMed ID: 32508048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
